Wan-Chih Su
Wan-Chih Su, Ph.D., is a Principal Scientist at Genentech, where she focuses on developing innovative high-throughput analytical platforms to support small molecules and new drug modalities, including oligonucleotide and peptide drug product development. Her research focuses on high-throughput chromatography, capillary electrophoresis, and spectroscopic methods for impurity profiling and characterization of complex formulations, including mRNA-lipid nanoparticle systems. Before joining Genentech, she earned her Ph.D. from the University of California, Davis, and has since contributed to advancing analytical strategies that bridge fundamental biophysical and separation sciences to biopharmaceutical applications. Her recent work highlights the development of high-throughput analytical methods for quantifying mRNA-LNP formulations.